Superantigen YPMa Exacerbates the Virulence ofYersinia pseudotuberculosisin Mice
- 1 May 2000
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (5) , 2553-2559
- https://doi.org/10.1128/iai.68.5.2553-2559.2000
Abstract
Yersinia pseudotuberculosis, a gram-negative bacterium responsible for enteric and systemic infection in humans, produces a superantigenic toxin designated YPMa (Y. pseudotuberculosis-derived mitogen). To assess the role of YPMa in the pathogenesis ofY. pseudotuberculosis, we constructed a superantigen-deficient mutant and compared its virulence in a mouse model of infection to the virulence of the wild-type strain. Determination of the survival rate after intravenous (i.v.) bacterial inoculation of OF1 mice clearly showed that inactivation ofypmA, encoding YPMa, reduced the virulence ofY. pseudotuberculosis. Mice infected i.v. with 104and 105wild-type bacteria died within 9 days, whereas mice infected with theypmAmutant survived 12 and 3 days longer, respectively. This decreased virulence of theypmAmutant strain was not due to an impaired colonization of the spleen, liver, or lungs. In contrast to i.v. challenge, bacterial inoculation by the intragastric (i.g.) route did not reveal any difference in virulence between wild-typeY. pseudotuberculosisand theypmAmutant since the 50% lethal doses were identical for both strains. Moreover, inactivation ofypmAgene did not affect the bacterial growth ofY. pseudotuberculosisin Peyer's patches, mesenteric lymph nodes (MLNs), and spleen after oral infection. Histological studies of spleen, liver, lungs, heart, Peyer's patches, and MLNs after i.v. or i.g. challenge with the wild type or theypmAmutant did not reveal any feature that can be specifically related to YPMa. Our data show that the superantigenic toxin YPMa contributes to the virulence ofY. pseudotuberculosisin systemic infection in mice.Keywords
This publication has 72 references indexed in Scilit:
- Studies on transformation of Escherichia coli with plasmidsPublished by Elsevier ,2006
- Report of four cases ofYersinia pseudotuberculosis septicemia and a literature reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Purification and characterization of a novel superantigen produced by a clinical isolate of Yersinia pseudotuberculosisFEBS Letters, 1994
- A Superantigen as Virulence Factor in an Acute Bacterial InfectionThe Journal of Infectious Diseases, 1994
- Clinical manifestations ofYersinia pseudotuberculosis infection in childrenEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989
- Two Outbreaks of Yersinia pseudotuberculosis 5a Infection in JapanScandinavian Journal of Infectious Diseases, 1989
- A Broad Host Range Mobilization System for In Vivo Genetic Engineering: Transposon Mutagenesis in Gram Negative BacteriaBio/Technology, 1983
- Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5''-aminoglycoside phosphotransferase type IIIGene, 1983
- A procedure for the isolation of deoxyribonucleic acid from micro-organismsJournal of Molecular Biology, 1961